TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||||||||
1. Identity of the issuer or the underlying issuer |
Immupharma plc |
|||||||||
2. Reason for the notification (please tick the appropriate box or boxes): |
||||||||||
An acquisition or disposal of voting rights |
x |
|||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||||||||
An event changing the breakdown of voting rights |
||||||||||
Other (please specify): |
|
|||||||||
3. Full name of person(s) subject to the |
Lanstead Capital LP |
|||||||||
4. Full name of shareholder(s) |
||||||||||
5. Date of the transaction and date on |
25 February 2016 |
|||||||||
6. Date on which issuer notified: |
26 February 2016 |
|||||||||
7. Threshold(s) that is/are crossed or |
3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15% |
|||||||||
8. Notified details: |
||||||||||
A: Voting rights attached to shares |
||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||
GB0033711010 |
0 |
0 |
17,872,341 |
17,872,341 |
15.03% |